Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Effects of apigenin on the function of human α7-nicotinic acetylcholine receptors expressed in Xenopus oocytes.

Created on 08 Sep 2025

Authors

Keun-Hang Susan Yang, Syed Nurulain, Tatiana Prytkova, Bassem Sadek, Lina T Al Kury, Sonia Hasan, Dmytro Isaev, Murat Oz

Published in

Natural product research. Pages 1-16. Mar 02, 2025. Epub Mar 02, 2025.

Abstract

The effects of apigenin, a plant flavonoid, were investigated using the two-electrode voltage-clamp technique on the function of the cloned α7 subunit of the human nicotinic acetylcholine (α7-nACh) receptor expressed in Xenopus oocytes. Currents induced by ACh (100 μM) were reversibly potentiated by apigenin with an EC50 value of 5.4 µM in a voltage-independent manner. In addition, potentiation by apigenin was significantly diminished by increasing ACh concentrations. Furthermore, apigenin (30 µM) did not alter the specific binding of [125I] α-bungarotoxin in oocyte membranes. Moreover, 30 µM apigenin also potentiated [3H] norepinephrine release evoked by nicotine (30 µM) in rat hippocampal slices. Finally, our docking studies carried out for apigenin on nicotinic α7-nACh receptors suggest that apigenin binds to the transmembrane region of the receptor as an allosteric modulator. Taken together, our results indicate that apigenin allosterically potentiates the function of the human α7-nACh receptors expressed in Xenopus oocytes and hippocampal slices.

PMID:
40920349
Bibliographic data and abstract were imported from PubMed on 08 Sep 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 74
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement